These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 307736)

  • 1. [Soluble nuclear antigens and their antibodies: a new path in the immunological study of connective tissue diseases].
    Peltier AP
    Nouv Presse Med; 1978 May; 7(21):1809-11. PubMed ID: 307736
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies to soluble nuclear antigens in connective tissue diseases].
    Rivero S; Jacobelli S
    Rev Med Chil; 1982 May; 110(5):433-8. PubMed ID: 6984534
    [No Abstract]   [Full Text] [Related]  

  • 4. New directions in antinuclear antibody research: the Sm, RNP, Ro, and La antigens are found on small-RNA protein particles.
    Hardin JA; Lerner MR; Lerner EA; Steitz JA
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):98-100. PubMed ID: 6179414
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mixed connective tissue disease, a clinical syndrome with anti-ribonucleoprotein antibodies].
    Elling H
    Ugeskr Laeger; 1978 Dec; 140(50):3140-2. PubMed ID: 310186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cellular ribonucleoprotein antigens].
    Zietkiewicz E; Słomski R
    Postepy Biochem; 1985; 31(2):337-64. PubMed ID: 2419885
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of two new soluble nuclear antigens reactive with sera of patients with connective tissue diseases.
    Miyawaki S; Kohmoto K; Kurata N; Ofuji T
    Arthritis Rheum; 1978; 21(7):803-10. PubMed ID: 358992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical usefulness of determining the antibodies to soluble nuclear antigens in various collagen diseases].
    Dziankowska-Bartkowiak B; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Torzecka D; Waszczykowska E
    Przegl Dermatol; 1990; 77(5):332-5. PubMed ID: 2125351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of antibodies to nuclear ribonucleoprotein in collagen diseases (author's transl)].
    Takano M
    Ryumachi; 1978 Jul; 18(4):256-66. PubMed ID: 308699
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix.
    Fritzler MJ; Ali R; Tan EM
    J Immunol; 1984 Mar; 132(3):1216-22. PubMed ID: 6198384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
    Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
    Farber SJ; Bole GG
    Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and clinical evaluation of antibodies against soluble nuclear antigens].
    Sánchez-Ibarrola A
    Allergol Immunopathol (Madr); 1983; 11(3):201-6. PubMed ID: 6605081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies against extractable nuclear antigens. Clinico-biological correlations in 100 cases].
    Barbouch MR; Gorgi Y; Ayed K; Haddad S; Ben Ayed H
    Rev Rhum Mal Osteoartic; 1989 Apr; 56(5):389-94. PubMed ID: 2499031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoreactivity to nuclear antigens in systemic lupus erythematosus with or without nephritis, and in other connective tissue diseases, with particular reference to the RNA-protein antigen.
    Mulli JC; Cruchaud A
    Int Arch Allergy Appl Immunol; 1977; 53(3):279-89. PubMed ID: 300712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies against antigens of soluble fraction in rheumatic diseases].
    Ivanova SM
    Ter Arkh; 1981; 53(11):135-9. PubMed ID: 7041312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.